G Medical Innovations Ownership 2024 | Who Owns G Medical Innovations Now?
Institutional Ownership
10.81%
Insider Ownership
15.28%
Retail Ownership
73.90%
Institutional Holders
13.00
G Medical Innovations Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7.50% | 1.07% | 1,350,000 | 1,350,000 | 100.00% | 1,228,500,000 | Mar 31, 2023 |
| AWM INVESTMENT COMPANY, INC. | 5.55% | 0.12% | 1,000,000 | 1,000,000 | 100.00% | 910,000,000 | Mar 31, 2023 |
| PERKINS CAPITAL MANAGEMENT INC | 1.11% | 0.17% | 200,000 | 200,000 | 100.00% | 182,000 | Mar 31, 2023 |
| BARCLAYS PLC | 0.31% | - | 56,000 | 56,000 | 100.00% | 51,000 | Mar 31, 2023 |
| ARMISTICE CAPITAL, LLC | 0.16% | 0.00% | 28,572 | 1 | 0.00% | 25,143,000 | Mar 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | 0.14% | 0.00% | 25,000 | 25,000 | 100.00% | 22,750,000 | Mar 31, 2023 |
| REGAL PARTNERS LTD | 0.08% | 0.00% | 15,211 | 15,211 | 100.00% | 13,842,000 | Mar 31, 2023 |
| CLEAR STREET LLC | 0.03% | 0.00% | 4,925 | 4,925 | 100.00% | 4,000 | Mar 31, 2023 |
| MACQUARIE GROUP LTD | 0.02% | - | 2,925 | 2,925 | 100.00% | 2,661,000 | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | 0.00% | - | 47 | 47 | 100.00% | 43,000 | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 20 | 20 | 100.00% | 18,000 | Mar 31, 2023 |
| MACQUARIE GROUP LTD | - | - | - | -2,925 | -100.00% | - | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | - | - | - | -47 | -100.00% | - | Mar 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -60,164 | -100.00% | - | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -20 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -1,240 | -100.00% | - | Mar 31, 2023 |
| REGAL PARTNERS LTD | - | - | - | -15,213 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2,193 | -100.00% | - | Mar 31, 2023 |
G Medical Innovations's largest institutional shareholder is SABBY MANAGEMENT, LLC, holding 7.50% of the company's total share outstanding, currently valued at $1.23B. The top 10 institutional shareholders own together 14.90% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7.50% | 1.07% | 1,350,000 | 1,350,000 | 100.00% | 1,228,500,000 | Mar 31, 2023 |
| PERKINS CAPITAL MANAGEMENT INC | 1.11% | 0.17% | 200,000 | 200,000 | 100.00% | 182,000 | Mar 31, 2023 |
| AWM INVESTMENT COMPANY, INC. | 5.55% | 0.12% | 1,000,000 | 1,000,000 | 100.00% | 910,000,000 | Mar 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | 0.14% | 0.00% | 25,000 | 25,000 | 100.00% | 22,750,000 | Mar 31, 2023 |
| REGAL PARTNERS LTD | 0.08% | 0.00% | 15,211 | 15,211 | 100.00% | 13,842,000 | Mar 31, 2023 |
| ARMISTICE CAPITAL, LLC | 0.16% | 0.00% | 28,572 | 1 | 0.00% | 25,143,000 | Mar 31, 2023 |
| CLEAR STREET LLC | 0.03% | 0.00% | 4,925 | 4,925 | 100.00% | 4,000 | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | 0.00% | - | 47 | 47 | 100.00% | 43,000 | Mar 31, 2023 |
| BARCLAYS PLC | 0.31% | - | 56,000 | 56,000 | 100.00% | 51,000 | Mar 31, 2023 |
| MACQUARIE GROUP LTD | 0.02% | - | 2,925 | 2,925 | 100.00% | 2,661,000 | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 20 | 20 | 100.00% | 18,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -1,240 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2,193 | -100.00% | - | Mar 31, 2023 |
| MACQUARIE GROUP LTD | - | - | - | -2,925 | -100.00% | - | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | - | - | - | -47 | -100.00% | - | Mar 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -60,164 | -100.00% | - | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -20 | -100.00% | - | Mar 31, 2023 |
| REGAL PARTNERS LTD | - | - | - | -15,213 | -100.00% | - | Mar 31, 2023 |
The largest G Medical Innovations shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 1.35M shares of G Medical Innovations (GMVD), representing 1.07% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7.50% | 1.07% | 1,350,000 | 1,350,000 | 100.00% | 1,228,500,000 | Mar 31, 2023 |
| AWM INVESTMENT COMPANY, INC. | 5.55% | 0.12% | 1,000,000 | 1,000,000 | 100.00% | 910,000,000 | Mar 31, 2023 |
| PERKINS CAPITAL MANAGEMENT INC | 1.11% | 0.17% | 200,000 | 200,000 | 100.00% | 182,000 | Mar 31, 2023 |
| BARCLAYS PLC | 0.31% | - | 56,000 | 56,000 | 100.00% | 51,000 | Mar 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | 0.14% | 0.00% | 25,000 | 25,000 | 100.00% | 22,750,000 | Mar 31, 2023 |
| REGAL PARTNERS LTD | 0.08% | 0.00% | 15,211 | 15,211 | 100.00% | 13,842,000 | Mar 31, 2023 |
| CLEAR STREET LLC | 0.03% | 0.00% | 4,925 | 4,925 | 100.00% | 4,000 | Mar 31, 2023 |
| MACQUARIE GROUP LTD | 0.02% | - | 2,925 | 2,925 | 100.00% | 2,661,000 | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | 0.00% | - | 47 | 47 | 100.00% | 43,000 | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 20 | 20 | 100.00% | 18,000 | Mar 31, 2023 |
| ARMISTICE CAPITAL, LLC | 0.16% | 0.00% | 28,572 | 1 | 0.00% | 25,143,000 | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -20 | -100.00% | - | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | - | - | - | -47 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -1,240 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2,193 | -100.00% | - | Mar 31, 2023 |
| MACQUARIE GROUP LTD | - | - | - | -2,925 | -100.00% | - | Mar 31, 2023 |
| REGAL PARTNERS LTD | - | - | - | -15,213 | -100.00% | - | Mar 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -60,164 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, G Medical Innovations's largest institutional buyer is SABBY MANAGEMENT, LLC. The company purchased 1.35M stocks of GMVD, valued at $1.23B.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -60,164 | -100.00% | - | Mar 31, 2023 |
| REGAL PARTNERS LTD | - | - | - | -15,213 | -100.00% | - | Mar 31, 2023 |
| MACQUARIE GROUP LTD | - | - | - | -2,925 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2,193 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -1,240 | -100.00% | - | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | - | - | - | -47 | -100.00% | - | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -20 | -100.00% | - | Mar 31, 2023 |
| ARMISTICE CAPITAL, LLC | 0.16% | 0.00% | 28,572 | 1 | 0.00% | 25,143,000 | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 20 | 20 | 100.00% | 18,000 | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | 0.00% | - | 47 | 47 | 100.00% | 43,000 | Mar 31, 2023 |
| MACQUARIE GROUP LTD | 0.02% | - | 2,925 | 2,925 | 100.00% | 2,661,000 | Mar 31, 2023 |
| CLEAR STREET LLC | 0.03% | 0.00% | 4,925 | 4,925 | 100.00% | 4,000 | Mar 31, 2023 |
| REGAL PARTNERS LTD | 0.08% | 0.00% | 15,211 | 15,211 | 100.00% | 13,842,000 | Mar 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | 0.14% | 0.00% | 25,000 | 25,000 | 100.00% | 22,750,000 | Mar 31, 2023 |
| BARCLAYS PLC | 0.31% | - | 56,000 | 56,000 | 100.00% | 51,000 | Mar 31, 2023 |
| PERKINS CAPITAL MANAGEMENT INC | 1.11% | 0.17% | 200,000 | 200,000 | 100.00% | 182,000 | Mar 31, 2023 |
| AWM INVESTMENT COMPANY, INC. | 5.55% | 0.12% | 1,000,000 | 1,000,000 | 100.00% | 910,000,000 | Mar 31, 2023 |
| SABBY MANAGEMENT, LLC | 7.50% | 1.07% | 1,350,000 | 1,350,000 | 100.00% | 1,228,500,000 | Mar 31, 2023 |
As of Mar 31 2023, G Medical Innovations's biggest institutional seller is JPMORGAN CHASE & CO. The company sold -60.16K shares of GMVD, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7.50% | 1.07% | 1,350,000 | 1,350,000 | 100.00% | 1,228,500,000 | Mar 31, 2023 |
| AWM INVESTMENT COMPANY, INC. | 5.55% | 0.12% | 1,000,000 | 1,000,000 | 100.00% | 910,000,000 | Mar 31, 2023 |
| PERKINS CAPITAL MANAGEMENT INC | 1.11% | 0.17% | 200,000 | 200,000 | 100.00% | 182,000 | Mar 31, 2023 |
| BARCLAYS PLC | 0.31% | - | 56,000 | 56,000 | 100.00% | 51,000 | Mar 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | 0.14% | 0.00% | 25,000 | 25,000 | 100.00% | 22,750,000 | Mar 31, 2023 |
| REGAL PARTNERS LTD | 0.08% | 0.00% | 15,211 | 15,211 | 100.00% | 13,842,000 | Mar 31, 2023 |
| CLEAR STREET LLC | 0.03% | 0.00% | 4,925 | 4,925 | 100.00% | 4,000 | Mar 31, 2023 |
| MACQUARIE GROUP LTD | 0.02% | - | 2,925 | 2,925 | 100.00% | 2,661,000 | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | 0.00% | - | 47 | 47 | 100.00% | 43,000 | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | 0.00% | - | 20 | 20 | 100.00% | 18,000 | Mar 31, 2023 |
G Medical Innovations's largest new institutional shareholder by number of shares is SABBY MANAGEMENT, LLC, purchased 1.35M shares, valued at $1.23B, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -60,164 | -100.00% | - | Mar 31, 2023 |
| REGAL PARTNERS LTD | - | - | - | -15,213 | -100.00% | - | Mar 31, 2023 |
| MACQUARIE GROUP LTD | - | - | - | -2,925 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2,193 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -1,240 | -100.00% | - | Mar 31, 2023 |
| HIGHMARK WEALTH MANAGEMENT LLC | - | - | - | -47 | -100.00% | - | Mar 31, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -20 | -100.00% | - | Mar 31, 2023 |
G Medical Innovations's largest sold out institutional shareholder by shares sold is JPMORGAN CHASE & CO, sold -60.16K shares, valued at -, as of undefined.
G Medical Innovations Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Sep, 22 | 13 | 8.33% |
| 30 Jun, 22 | 12 | 20.00% |
| 31 Mar, 22 | 10 | 66.67% |
| 31 Dec, 21 | 6 | 20.00% |
| 30 Sep, 21 | 5 | 66.67% |
| 30 Jun, 21 | 3 | - |
As of 30 Sep 22, 13 institutions are holding G Medical Innovations's shares, representing an increase of 8.33% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Sep, 22 | 1,227,720 | 34.34% |
| 30 Jun, 22 | 913,880 | 156.22% |
| 31 Mar, 22 | 356,672 | 23.65% |
| 31 Dec, 21 | 288,451 | 2.61% |
| 30 Sep, 21 | 281,126 | 6.02% |
| 30 Jun, 21 | 265,164 | - |
G Medical Innovations (GMVD) has 1.23M shares outstanding as of 30 Sep 22, up 34.34% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Sep, 22 | 10.81% | 16.69% |
| 30 Jun, 22 | 8.05% | 81.58% |
| 31 Mar, 22 | 3.14% | 48.68% |
| 31 Dec, 21 | 2.54% | 41.45% |
| 30 Sep, 21 | 2.48% | 45.40% |
| 30 Jun, 21 | 2.33% | - |
As of 30 Sep 22, G Medical Innovations is held by 10.81% institutional shareholders, representing a 16.69% growth compared to 30 Jun 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Sep, 22 | 7 | 16.67% |
| 30 Jun, 22 | 6 | -14.29% |
| 31 Mar, 22 | 7 | 133.33% |
| 31 Dec, 21 | 3 | -40.00% |
| 30 Sep, 21 | 5 | 66.67% |
| 30 Jun, 21 | 3 | - |
7 institutional shareholders have increased their position in GMVD stock as of 30 Sep 22 compared to 6 in the previous quarter (a 16.67% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Sep, 22 | 1 | -50.00% |
| 30 Jun, 22 | 2 | -33.33% |
| 31 Mar, 22 | 3 | 50.00% |
| 31 Dec, 21 | 2 | - |
| 30 Sep, 21 | - | - |
| 30 Jun, 21 | - | - |
1 institutional shareholders have reduced their position in GMVD stock as of 30 Sep 22 compared to 2 in the previous quarter (a -50.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Sep, 22 | 13 | 8.33% | 1,227,720 | 34.34% | 10.81% | 16.69% | 7 | 16.67% | 1 | -50.00% |
| 30 Jun, 22 | 12 | 20.00% | 913,880 | 156.22% | 8.05% | 81.58% | 6 | -14.29% | 2 | -33.33% |
| 31 Mar, 22 | 10 | 66.67% | 356,672 | 23.65% | 3.14% | 48.68% | 7 | 133.33% | 3 | 50.00% |
| 31 Dec, 21 | 6 | 20.00% | 288,451 | 2.61% | 2.54% | 41.45% | 3 | -40.00% | 2 | - |
| 30 Sep, 21 | 5 | 66.67% | 281,126 | 6.02% | 2.48% | 45.40% | 5 | 66.67% | - | - |
| 30 Jun, 21 | 3 | - | 265,164 | - | 2.33% | - | 3 | - | - | - |
G Medical Innovations Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of G Medical Innovations's stock was made by AWM Investment Company, Inc. on Apr 04 2023, selling 437,500 shares at $1.02 per share (valued at $446.64K).
G Medical Innovations Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 1 | - |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by G Medical Innovations's insiders, as of Q2 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 1 | - |
As of Q2 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of G Medical Innovations's stocks.
G Medical Innovations Peer Ownership
| Ticker | Company |
|---|---|
| FEMY | Femasys Inc. |
| ZJYL | Jin Medical International Ltd. |
| AKYA | Akoya Biosciences, Inc. |
| GCTK | GlucoTrack, Inc. |
| ATRI | Atrion Corporation |
| MBOT | Microbot Medical Inc. |
| MHUA | Meihua International Medical Technologies Co., Ltd. |
| POAI | Predictive Oncology Inc. |
| LUCY | Innovative Eyewear, Inc. |
| NXGL | NEXGEL, Inc. |
| PDEX | Pro-Dex, Inc. |
| STSS | Sharps Technology, Inc. |
GMVD Ownership FAQ
Who Owns G Medical Innovations?
G Medical Innovations is owned by institutional shareholders (10.81%), insiders (15.28%), and public (73.90%). The largest institutional shareholder of G Medical Innovations is SABBY MANAGEMENT, LLC (7.50% of total shares) and the top mutual fund owner is (0% of total shares).
Who are the major institutional shareholders of G Medical Innovations?
G Medical Innovations's major institutional shareholders are SABBY MANAGEMENT, LLC, AWM INVESTMENT COMPANY, INC., PERKINS CAPITAL MANAGEMENT INC, BARCLAYS PLC, and ARMISTICE CAPITAL, LLC. The top five shareholders own together 14.63% of the company's share outstanding.
How many G Medical Innovations shareholders are there?
As of Sep 2022, there are 13 institutional shareholders of G Medical Innovations.
What percentage of G Medical Innovations is owned by SABBY MANAGEMENT, LLC?
SABBY MANAGEMENT, LLC owns 1.35M shares of G Medical Innovations, representing 7.50% of the company's total shares outstanding, valued at $1.23B (as of Mar 2023).
What percentage of G Medical Innovations is owned by AWM INVESTMENT COMPANY, INC?
As of Mar 2023, AWM INVESTMENT COMPANY, INC holds 1M shares of G Medical Innovations (GMVD), compromising 5.55% of the company, valued at $910M.
What percentage of G Medical Innovations is owned by PERKINS CAPITAL MANAGEMENT INC?
PERKINS CAPITAL MANAGEMENT INC is the third largest holder of G Medical Innovations. The company owns 200K of the company's shares outstanding (worth $182K).